Introduction
Although the high incidence of obstructive coronary disease (CAD) [1, 2] , myocardial infarction (MI) and cardiovascular death in patients with chronic kidney disease (CKD) [3, 4] suggests that surgical revascularization of CAD should reduce mortality in the CKD population, uncertainty remains about how to maximize the benefits of coronary artery bypass grafting (CABG) in patients with CKD. Kidney function has been repeatedly identified as an important determinant of perioperative outcomes following CABG. In fact, the risk of in-hospital death may exceed 10% in patients with advanced CKD [5] [6] [7] -nearly 10-fold higher than the incidence in the pivotal trials comparing CABG and medical therapy in the general population in which absolute 5-year mortality was only 5.6% lower with CABG than medical therapy [8] .
These observations raise important questions about the appropriate role of CABG in patients with CKD and suggest that improved estimates of peri-CABG mortality and tools to estimate operative risk in CKD patients are needed to optimize utilization of CABG in the growing CKD population. Additionally, knowledge of non-fatal operative complications, long-term outcomes in CKD patients surviving to hospital discharge, and the association between perioperative events and in-hospital mortality remains limited. Improved understanding of each of these factors may also help maximize the benefits of CABG in the CKD population. We analysed patients undergoing CABG at the Brigham & Women's Hospital (BWH) in order to better elucidate the long and short-term outcomes of CABG in patients with CKD.
Materials and methods

Patient selection and data sources
Data on individuals undergoing CABG with or without concurrent valvular surgery at BWH between January 2005 and August 2008 were prospectively collected. Only the first operation for each individual during the observation period was included in the current analysis.
Data on baseline conditions and in-hospital events were recorded by physicians in the process of generating their clinical notes using pre-formatted, computerized templates with data fields defined consistent with the Society of Thoracic Surgeons definitions. Laboratory data and discharge medications were automatically uploaded from computerized pharmacy records and clinical information systems. Post-discharge death through the end of 2008 was ascertained using clinical information systems and the social security death index-a national index with a high sensitivity and specificity for the detection of mortality [9, 10] .
Definitions
Glomerular filtration rate (GFR) was assessed using the last preoperative creatinine and the modified Modification of Diet in Renal Disease equation [11] . Three categories of CKD were defined: normal renal function/ mild CKD [estimated GFR (eGFR) ≥60 mL/min/1.73 m 2 ], moderate CKD (eGFR 30-59.9 mL/min/1.73 m 2 ) and severe CKD (eGFR <30 mL/min/1.73 m 2 ). Operative status was defined as urgent/emergent -surgery required during initial hospitalization or due to ongoing refractory ischaemia-or elective surgery. Post-operative myocardial injury or post-operative infarction was defined by post-operative CK-MB l >1.5× the upper limit of normal within 24 h of surgery. Acute kidney injury (AKI) was defined as a ≥50% increase above baseline or change ≥0.3 mg/dL in serum creatinine. Stage 2 AKI was defined as a doubling of baseline creatinine [12] . Operative death was defined as death occurring prior to discharge or within 30 days of surgery.
Statistics
Summary statistics are presented as counts (percentage), mean±standard deviation (SD) or median (interquartile range, IQR) as appropriate. Univariate comparisons across CKD categories were performed using the Student's t-test or univariate ANOVA for normally distributed continuous variables, χ 2 tests for count variables, and the Mann-Whitney test or trend tests for non-normally distributed continuous variables.
Long-term survival was assessed using univariate and multivariate Cox proportional hazards regression after checking model assumptions graphically and with Schoenfeld residuals [13] . We built stepwise forward multivariable regression models with a probability of entry of P<0.15 and probability of retention of P<0.20. Age, sex and race were forced into the model. Renal function, congestive heart failure, prior cardiac surgery, concurrent valve surgery, chronic lung disease, recent MI, diabetes, history of stroke and obesity were considered for inclusion on the basis of their well-established associations with post-CABG outcomes [14, 15] .
To understand the determinants of in-hospital death among patients with moderate to severe CKD, we calculated univariate odds ratios (OR) for in-hospital death among patients with eGFR <60 mL/min/ 1.73 m 2 . Forward stepwise logistic regression models with entry and exit criteria as above were used to adjust for confounding and to build a tool that could be used to predict the risk of operative death in this population.
To avoid over-fitting, logistic models were run in each of 100 bootstrap samples. Variables retained in ≥50% of stepwise models were entered into an additional set of 100 bootstrapped regressions in order to generate final ORs and confidence intervals. Coefficients were rounded to the nearest integer, and the resulting score was entered into a final univariate logistic regression with in-hospital death as the dependant variable. Model fit and the area under the ROC curve (AUC) were evaluated in an additional series of bootstrap samples. Sensitivity and specificity of scores above the median for the prediction of in-hospital death were examined in a final series of 100 bootstrapped samples.
We compared the performance of our model with the logistic EuroSCORE-a standard risk tool [16, 17] . With the exception of pulmonary artery pressures, for which data was unavailable, variables used in the EuroSCORE were mapped from their nearest match within our data. The AUC was calculated for an initial assessment of model performance. Calibration and fit were tested with the Hosmer-Lemeshow goodness of fit test [18] , and discrimination of the two models was compared using the net re-classification index (NRI) [19] .
Analyses were performed in Stata, version 9.2 (Stata Corporation, College Station, TX, USA) with P<0.05 considered significant.
Human subjects
This project was approved by the BWH institutional review board.
Results
Baseline characteristics
During the observation period, 2438 patients underwent CABG with or without concurrent valve surgery. Ninetynine patients had severe CKD (mean eGFR 18.5±7.8 mL/ min/1.73 m 2 ), 625 had moderate CKD (eGFR 48.7 ± 7.9 mL/min/1.73 m 2 ) and 1714 had mild/no CKD (eGFR 85.4±17.1 mL/min/1.73 m 2 ). Median follow-up time was 2.32 years in patients with CKD, 2.41 years in patients with moderate CKD and 2.27 years in individuals with mild/no CKD.
In general, patients with severe or moderate CKD had greater degrees of co-morbidity, and were older, more likely to be male, and more likely to have diabetes, hypertension or peripheral vascular disease (P < 0.001 for all comparisons, Table 1 ). Patients with severe or moderate CKD were also more likely to require concurrent valvular surgery (42.4% and 40% vs. 27.0%, P<0.001) and to have a history of prior CABG (7.1% and 4.3% vs. 3.1%, P=0.05) than those with preserved renal function.
Perioperative outcomes
ICU stays were significantly longer in patients with CKD, and operative complications were more common ( Table 2 ). . AKI was more common in patients with severe CKD (46.6% of patients without ESRD at baseline) and moderate CKD (24.3%), but was also frequent in patients without significant CKD (12.8%) (P < 0.001). In contrast, severe AKI requiring dialysis was uncommon in patients without severe baseline CKD and occurred in <1% of patients with normal baseline function. Operative death was significantly more frequent in patients with severe CKD (7.1%) and moderate CKD (4.8%) than in patients with no/mild CKD (2.2%) (P < 0.001). Cause of death was not different across categories of renal function and was listed as cardiac in ∼50% of cases.
As shown in Table 3 , patients dying before discharge were characterized by a greater incidence of perioperative myocardial injury, cardiac arrest, stroke and AKI. They were also characterized by significantly higher use of red blood cell transfusion than survivors.
Association of baseline characteristics with mortality
Patients with severe CKD were more likely to die in the years following CABG (hazard ratio, HR 4.34, 95% CI 2.10-8.99) than individuals with moderate CKD (HR 2.73, 95% CI 1.71-4.29) or no/mild CKD (Figure 1 ). Older age, male sex, history of congestive heart failure, MI, cardiogenic shock and history of prior cardiac surgery were also strongly associated with mortality in unadjusted Cox regressions. Severe CKD (HR 2.77, 95% CI 1.00-2.68) and moderate CKD (HR 1.64, 95% CI 1.30-45.94) Within the severe CKD group, acute renal events are calculated only for patients not requiring dialysis at baseline (n=58).
Post-CABG outcomes in CKDremained independently associated with the risk of longterm mortality following multivariable proportional hazards regression (Table 4) . Interestingly, the vast majority of fatalities occurred perioperatively (Figure 1 ), and ≥97% of patients surviving to discharge remained alive at median of 2.34 years after their initial discharge in all the three groups. Unadjusted associations with perioperative death among patients with moderate to severe CKD are summarized in Table 5 . Older age, history of stroke, recent MI or congestive heart failure, prior cardiac surgery, cardiogenic shock, concurrent valve surgery, and urgent or emergent operative status had significant or borderline significant (P<0.10) associations with operative mortality in univariate logistic models. Among post-operative complications, blood transfusion, AKI, stroke, cardiac arrest and multi-organ failure were strongly associated with the risk of death.
Urgent or emergent operative status, prior cardiac surgery, concurrent valve surgery, history of stroke and cardiogenic shock were each selected in ≥50% of stepwise, logistic regressions run in bootstrap samples. Conversely, age and degree of renal failure were each selected in ≤35% of models. Except for stroke, each of the five selected factors was independently associated with the risk of operative death (Table 6 ). Discrimination of the final model was good (C-statistic 0.75, 95% CI 0.75-0.76, Figure 2A , Table 7 ).
Parameter estimates from this model were rounded to the nearest integer, and a predictive score with a range of 0-15 points was constructed. In models containing only this score, the odds of death increased 1.4-fold for each point, and the C-statistic was 0.74 (95% CI 0.73-0.75, Figure 2B ). Extremely high or low scores were highly specific for detecting operative mortality and survival, respectively, but were not sensitive for these outcomes. Scores above the 50th percentile of the distribution (score >4) had a 96.4% specificity for the identification of patients with moderate to severe CKD who experienced in-hospital death (sensitivity 24.6%). Conversely, scores below the 25th percentile (<2) had a specificity of 97.6% for survival to discharge (sensitivity 11.3%).
The EuroSCORE model was poorly calibrated, did not fit our data (P = 0.003) and consistently over-predicted mortality (data not shown). Discrimination was somewhat better, but the C-statistic of the EuroSCORE was only 0.68 (95% CI 0.60-0.77). At cut-offs of 1%, 5%, 10%, 15% and >15% in the predicted risk of operative death, the NRI was 3.6%-consistent with our predictive tool assigning 3.6% more of the population to an appropriate predictive category than the EuroSCORE. Although this difference was not significant (P=0.76), our model was significantly better at identifying individuals likely to survive to discharge (P<0.001).
Discussion
CKD is increasingly recognized as a condition characterized by a high incidence of CAD and cardiovascular death. Patients with CKD seem likely to benefit from the judicious use of surgical revascularization, but enthusiasm for broader use of CABG has been limited by the high risk of surgical mortality in patients with moderate to severe CKD. To better understand the risks and benefits of CABG in the CKD population, we analysed the outcomes among 2438 patients who underwent CABG between 2005 and 2008. Operative and long-term mortality rates were several-fold higher among patients with moderate or severe CKD than in individuals without significant renal impairment, but despite the increased 'relative' risk of mortality in patients with CKD, overall survival during the first few years after hospital discharge was high regardless of baseline eGFR.
Given the excellent long-term outcomes in CKD patients surviving surgery, we analysed factors associated with operative mortality, and developed a novel and simple scoring system that requires further validation but holds promise as a means of preoperatively identifying those CKD patients with a high likelihood of survival to discharge as well as those most likely to suffer a fatal outcome. Use of this type of tool could facilitate the targeted use of interventions designed to ameliorate the most common operative complications. Alternatively, it may facilitate the triage of high-risk patients to alternative therapies for their CAD. The high risk of operative death that we observed is consistent with prior studies demonstrating a risk of operative death in patients undergoing CABG that may exceed 10% in those with advanced CKD or ESRD [6, 7, [20] [21] [22] . Our findings suggest that this risk remains elevated in contemporary surgical cohorts, and that complications such as stroke, infection, requirement for transfusion and perioperative myocardial injury are also considerably more frequent in patients with CKD. Conversely, a novel feature of our analysis is our finding that long-term mortality rates are low in patients with moderate to severe CKD who survive the initial hospitalization-a rate several-fold lower than in CKD cohorts including patients without known coronary disease [23, 24] Few studies have specif ically compared 'postdischarge' survival according to baseline renal function, although a number of retrospective studies have suggested that, despite the operative risk, CABG is the preferred treatment for CAD in patients with CKD. One study of elderly MI patients with ESRD, for example, found that 1-year survival was 69% in patients undergoing CABG compared with 54% among patients treated percutaneous- ly and 45% in those treated medically [25] . Similar findings were observed by Herzog in ESRD patients undergoing a first coronary revascularization [26] , and by Reddan in a single-centre study of patients with various stages of CKD [27] . More recent studies have found excellent mid-term survival rates in individuals with non-dialysis-dependent CKD. In a study by Devbhandari including 386 patients with CKD, 86.2% of patients remained alive 2 years after discharge [28] . A similar study by Zakeri including 458 individuals with CKD found that survival was 81% at 3 years [21] . Neither of these analyses accounted for operative mortality in their estimates of long-term mortality-a difference which likely accounts for the slightly higher survival rates that we observed at 2 years in patients who were discharged alive.
Our study was not designed to compare mortality in patients undergoing CABG with those in the general CKD population, but the high survival rate in our cohort merits comment. A high prevalence of uncorrected and undiagnosed coronary disease [29, 30] in the general CKD population may explain why the survival rate was high in our post-CABG patients compared with the general CKD population. Selection of relatively healthy CKD patients for CABG or failure to capture all out of hospital deathswhich seems unlikely given the well-established validity of the social security death index [10] -offer alternative explanations.
Whatever the explanation, the high post-discharge survival we observed is consistent with earlier studies and suggests that benefits of CABG in CKD patients can be maximized by improving understanding of the relationship between operative events and the risk of death as well as by better preoperative risk-stratification. Most of the operative complications we analysed were more frequent in patients with CKD, and post-operative stroke, blood transfusion and AKI were strongly associated with the occurrence of operative death. In addition, the cause of death was frequently listed as infectious or neurologic. Although our data do not permit analysis of causality, these findings imply that interventions designed to reduce central ner- vous system ischaemia, blood transfusion, AKI and perhaps infection could potentially improve operative survival in patients with CKD. Further study is warranted.
The association of transfusion with mortality is particularly intriguing. CKD impairs erythrocytosis, and is associated with (preoperative) anaemia and increased risks of bleeding after CABG [31] . For these and other reasons, transfusion thresholds are likely to differ in patients with and without CKD. Our finding that transfusion was both more common and highly associated with mortality in the CKD group is consistent with the emerging evidence linking blood transfusion to increased rates of MI, AKI and death in patients with critical illness or those undergoing CABG [32, 33] . Although additional study to determine causality is needed, our analysis suggests that strategies to optimize preoperative haemoglobin and to minimize post-operative transfusion could improve operative outcomes in patients with CKD.
In addition to strategies aimed at reducing postoperative complications, better preoperative risk-stratifica- tion of CKD patients prior to CABG is needed, but we are unaware of any existing CKD-specific tools for this purpose. In this study, stroke, concurrent valve surgery, urgent operations, cardiogenic shock and prior cardiac surgery were all associated with an increased risk of operative death in patients with CKD. Each of these factors has been previously identified as a risk factor for operative death in the general population [14, 15] , and a CKD-specific score incorporating these factors was simple and successfully discriminated between patients at extremes of risk. Within our population, this model performed better than the Euro-SCORE, was less likely to overestimate the risk of death, and showed a good ability to discriminate individuals at the extremes of risk. Because this predictive tool was derived using a small dataset from a single centre and has not been externally validated, its use in clinical practice would be premature. External validation of this scoring system is clearly needed. However, we believe that our findings demonstrate the feasibility of identifying CKD patients who are highly likely to survive CABG and those highly unlikely to survive long enough to derive any benefit from CABG using simple, bedside scoring systems. Once validated, the clinical utility of these tools will need to be established by prospectively studying whether outcomes can be improved by using alternatives to CABG in patients identified as high-risk or by targeting these patients for interventions aimed at preventing the most frequent operative complications.
Several limitations of this study are worth noting. Outpatient creatinine was not routinely available, and GFR was estimated from the preoperative serum creatinine. Misclassification of GFR may have occurred in some cases. Secondly, we analysed patients from a singletertiary referral centre. Although operative mortality rates were comparable to those in multi-centre studies, important differences in the characteristics of patients and surgical staff may exist, and our results require confirmation in other cohorts before they can readily be generalized. Finally, the small number of patients with advanced CKD and modest number of deaths in the moderate to severe CKD cohort limited our ability to specifically study individuals with stage 5 CKD, to simultaneously adjust for more than a few confounders, or to split our cohort into derivation and validation sets. Bootstrap re-sampling was used to mitigate over-fitting of our models to the current dataset, but refinement and validation in larger cohorts are needed.
In conclusion, in a large cohort of patients undergoing CABG, we found that, despite the high risk of operative death in patients with CKD, long-term mortality among those surviving to discharge was low. Our findings suggest that CABG may effectively reduce the risk of death in well-selected patients with moderate to severe CKD. We further found that a history of prior cardiac surgery or stroke, preoperative cardiogenic shock, and the need for urgent surgery or concurrent valve surgery identify CKD patients with markedly increased risks of operative death. A simple predictive tool incorporating these factors holds promise as a way of preoperatively identifying CKD patients who can undergo CABG safely as well as their counterparts who are unlikely to survive an operation and derive long-term benefit from CABG.
